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Abstract
In eukaryotic cell nuclei, DNA associates with the core histones H2A, H2B, H3 and H4 to form nucleosomal core particles. DNA
binding to histones is regulated by posttranslational modifications of N-terminal tails (e.g., acetylation and methylation of histones).
These modifications play important roles in the epigenetic control of chromatin structure. Recently, evidence that biotinidase and
holocarboxylase synthetase (HCS) catalyze the covalent binding of biotin to histones has been provided. The primary aim of this
study was to identify biotinylation sites in histone H2A and its variant H2AX. Secondary aims were to determine whether acetylation
and methylation of histone H2A affect subsequent biotinylation and whether biotinidase and HCS localize to the nucleus in human
cells. Biotinylation sites were identified using synthetic peptides as substrates for biotinidase. These studies provided evidence that
K9 and K13 in the N-terminus of human histones H2A and H2AX are targets for biotinylation and that K125, K127 and K129 in
the C-terminus of histone H2A are targets for biotinylation. Biotinylation of lysine residues was decreased by acetylation of adjacent
lysines but was increased by dimethylation of adjacent arginines. The existence of biotinylated histone H2A in vivo was confirmed
by using modification-specific antibodies. Antibodies to biotinidase and HCS localized primarily to the nuclear compartment,
consistent with a role for these enzymes in regulating chromatin structure. Collectively, these studies have identified five novel
biotinylation sites in human histones; histone H2A is unique among histones in that its biotinylation sites include amino acid residues
from the C-terminus.
Published by Elsevier Inc.
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1. Introduction
Histones are quantitatively and qualitatively important
DNA-binding proteins in eukaryotic cells. The following
five major classes of histones have been identified: H1,
H2A, H2B, H3 and H4 [1]. Histones carry a positive net
charge due to the great abundance of arginine and lysine
residues in these proteins [1]. The binding of negatively
charged DNA to positively charged histones is mediated by
electrostatic interactions. In chromatin, stretches of 146 base
pairs of DNA are wrapped around octamers of core histones
(one H3–H3–H4–H4 tetramer and two H2A–H2B dimers)
to form nucleosomal core particles. Linker histone H1
associates with the DNA connecting two core particles to
complete the nucleosomal assembly [1].
N-terminal tails of histones are exposed at the nucleo-
somal surface [1]. Lysine, arginine, serine, threonine and
glutamate residues in these tails are targets for posttransla-
tional modifications such as acetylation, methylation,
ubiquitination, phosphorylation, sumoylation and poly(ADP
ribosylation) [2]. These covalent modifications play impor-
tant roles in the epigenetic control of chromatin structure,
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genomic stability and gene expression [3–5]. Some regions
in C-terminal domains (e.g., hinge regions) are also
exposed at the nucleosomal surface and are potential
targets for covalent modifications [1]. For example, K120
in histone H2B is a target for ubiquitination [6], and K108,
K116, K120 and K125 in histone H2B are targets for
acetylation [7]. Histone H2A is unique among core
histones in having its C-terminal tail exposed at the
nucleosomal surface [1,8]. Consistent with this observa-
tion, the following modifications have been identified in
the C-terminus of histone H2A and its variant H2AX:
ubiquitination of K119 [6,9] and phosphorylation of S139
[10,11], respectively.
Recently, a novel posttranslational modification of
histones has been identified: biotinylation of lysine
residues [12]. The covalent binding of biotin to histones
is mediated by biotinidase and holocarboxylase synthe-
tase (HCS) [13,14]. Biotinidase uses biocytin (biotinyl-
q-lysine) as a substrate for biotinylation of histones [13],
whereas HCS uses biotin and ATP [14]. The following
biotinylation sites have been identified in human histo-
nes: K4, K9 and K18 in histone H3 [15] and K8 and
K12 in histone H4 [16]. Biotinylation of histones plays a
role in the regulation of gene expression [17], cell
proliferation [12,14] and the cellular response to DNA
damage [17,18].
Previous studies suggested that histone H2A contains
streptavidin-reactive material [12], consistent with biotiny-
lation of this protein. In this study, we tested the
hypothesis that specific lysine residues in histone H2A
and its variant H2AX are targets for biotinylation by
biotinidase. Histones H2A and H2AX were chosen as
models for the following reasons: First, both histones H2A
and H2AX contain biotinylation motifs in their N-terminal
and C-terminal domains (A. Kueh and J. Zempleni,
unpublished observations). Second, the N-terminal and
C-terminal regions of histone H2A have important
functions in telomeric silencing in yeast [19]. Third,
phosphorylation of histone H2AX plays a role in the
cellular response to DNA damage [11]. Fourth, various
posttranslational modifications are known to occur in
histone H2A (e.g., phosphorylation of S1 [20], acetylation
of K5, K9 [21] and K13 [7], ubiquitination of K119 [6,9],
phosphorylation of T120 [22] and methylation of K125 or
K127 [7]. Likely, these modifications affect subsequent
biotinylation [16]. Collectively, identification of biotinyla-
tion sites in histones H2A and H2AX is likely to produce
valuable insights into roles of these histones in chromatin
structure and genomic stability.
This study addressed the following specific aims:
First, we sought to identify the amino acid residues in
histones H2A and H2AX that are targets for biotinyla-
tion by biotinidase. Second, we sought to determine
whether acetylation, methylation and phosphorylation of
histone H2A affect its subsequent biotinylation by
biotinidase. Third, we sought to determine whether
biotinidase and HCS localize to the nucleus in human
cells, consistent with a role of these enzymes in histone
biotinylation in vivo.
2. Methods and materials
2.1. Identification of biotinylation sites
In previous studies, we developed a procedure to
identify amino acid residues in histones that are targets for
biotinylation [23]. Briefly, this procedure is based on the
following analytical sequence: (1) short peptides (b20
amino acids in length) are synthesized chemically; amino
acid sequences in these peptides are based on the
sequence in a given region of a histone; (2) peptides
are incubated with biotinidase or HCS to conduct
enzymatic biotinylation; and (3) peptides are resolved by
gel electrophoresis and peptide-bound biotin is probed
using streptavidin peroxidase. Amino acid substitutions
(e.g., lysine-to-alanine substitutions) in synthetic peptides
are used to corroborate identification of biotinylation sites.
In addition, amino acid modifications (e.g., acetylation of
lysines) in peptides can be used to investigate the cross-
talk between biotinylation of histones and other known
modifications of histones.
In this study, peptides were synthesized based on the
amino acid sequences in human H2A.1 (GenBank acces-
sion number M60752) and H2AX (GenBank accession
number P16104). Peptides were synthesized using N-
fluoren-9-ylmethoxycarbonyl (Fmoc)-activated l-isomers
of amino acids [16]. One-letter annotation is used for
denoting amino acids in this article [24]. Chemically
modified peptides were synthesized by using biotinylated,
acetylated and dimethylated q-NH2-derivatives of Fmoc-
lysine, dimethylated guanidino derivatives of Fmoc-arginine
and phosphorylated derivatives of Fmoc-serine. Peptides
were quantified as described [16]. Identities of peptides
were confirmed by matrix-assisted laser desorption ioniza-
tion (MALDI)—time of flight—and by quadrupole—time
of flight mass spectrometry—at the Nebraska Center of
Mass Spectrometry (University of Nebraska–Lincoln, Lin-
coln, NE, USA). Amino acid sequences of synthetic
peptides are provided in Results.
Peptides from both the N-terminal and C-terminal
regions of histones H2A and H2AX were included in the
analysis of biotinylation sites. Synthetic peptides were
biotinylated enzymatically as described previously [16]
with the following modifications: 5 Ag of a given peptide
was dissolved in 100 Al of a mixture containing 15 Al of
human plasma (as a source of biotinidase), 10 Al of
biocytin solution (75 Amol/L final concentration, as a
source of biotin) and 75 Al of Tris buffer (50 mmol/L final
concentration, pH 8.0). Samples were incubated at 378C
for up to 45 min. Reactions were quenched by adding an
equal volume of Tricine gel loading buffer (Invitrogen,
Carlsbad, CA, USA). Peptides were resolved by gel
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electrophoresis and peptide-bound biotin was probed by
using streptavidin peroxidase [16].
2.2. Polyclonal antibodies
The following biotinylation sites were identified in
histone H2A in the experiments described below: K9 and
K13 in the N-terminal region and K125, K127 and K129 in
the C-terminal region. We generated antibodies against
K9-biotinylated histone H2A and K13-biotinylated histone
H2A. In addition, we generated antibodies against the two
human enzymes that mediate biotinylation of histones:
biotinidase and HCS. Polyclonal antibodies were produced
using a commercial facility (Cocalico Biologicals, Reams-
town, PA, USA). The following peptides were synthesized
by AnaSpec (San Jose, CA, USA) and the University of
Virginia Biomolecular Research Facility (Charlottesville,
VA, USA) for injection into rabbits: (1) N1–12bio-
K9=SGRGKQGGK(biotin)ARAC (amino acids 1–12 in
histone H2A plus a cysteine); (2) N
10–24
bioK13=ARAK
(biotin)AKTRSSRAGLQC (amino acids 10–25 in histone
H2A plus a cysteine); (3) biotinidase (GenBank accession
number NM_000060)=CLRKSRLSSGLVTAALYGR-
LYERD (amino acids 520–542 in biotinidase plus one
cysteine); and (4) HCS (GenBank accession number
NM_000411)=EHVGRDDPKALGEEPKQRRGC (amino
acids 58–77 in HCS plus one cysteine). Identities and
purities of these peptides were confirmed by using high-
performance liquid chromatography and MALDI (data not
shown). Peptides were conjugated to keyhole limpet
hemocyanin before injection into White New Zealand
rabbits [16]. Rabbit serum was collected before (preimmune
serum) and after three injections with peptides mixed with
Freund’s adjuvant over a period of 49 days. Immunoglob-
ulin G was purified from serum by using an ImmunoPure
(A) IgG Purification Kit (Pierce, Rockford, IL, USA)
according to the manufacturer’s protocol. Antibody specif-
icities were investigated by using synthetic peptides and
histone extracts from human cells as described [16].
2.3. Cell culture
Human-derived Jurkat lymphoma cells and JAr chorio-
carcinoma cells (ATCC, Manassas, VA, USA) were cultured
as described [25,26]. Acid extracts from Jurkat cell nuclei
[12] were used for Western blot analysis of biotinylated
histone H2A [16], whereas JAr cells were used for analysis
of biotinylated histone H2A by immunocytochemistry.
2.4. Immunocytochemistry
K9-biotinylated histone H2A, K13-biotinylated histone
H2A, biotinidase and HCS were visualized in JAr cells by
using immunocytochemistry as described [27]. Primary
antibodies were as described above. We used donkey anti-
rabbit Cy2-labeled antibody (Jackson ImmunoResearch,
West Grove, PA, USA) as a secondary antibody. Cytoplas-
mic and nuclear compartments were stained with rhoda-
mine phalloidin and 4V, 6-diamidino-2-phenylindole (DAPI)
(Sigma, St. Louis, MO, USA) as described [27]. Images
were obtained by using an Olympus FV500 confocal
microscope (Microscopy Core Facility, University of
Nebraska–Lincoln).
3. Results
3.1. Biotinylation sites in histones H2A and H2AX
Both the N-terminal and C-terminal of histone H2A
contain targets for biotinylation by biotinidase. We synthe-
sized the following five peptides based on the N-terminal
and C-terminal of histone H2A: N1–9=amino acid sequence
SGRGKQGGK; N7–14 = GGKARAKA; N12–20 =
AKAKTRSSR; C113–121=AVLLPKKTE; and C122–129=
SHHKAKGK; subscript numbers denote the position of
amino acid residues in histone H2A. These peptides were
subjected to enzymatic biotinylation and peptide-bound
biotin was probed using gel electrophoresis and streptavidin
peroxidase. Both N1–9 and N7–14 were good targets for
biotinylation by biotinidase but N12–20 was not a good target
(Fig. 1, Lanes 1–3). Moreover, peptide C113–121 was not but
C122–129 was a good target for biotinylation (Lanes 4 and 5).
Previous studies are consistent with the hypothesis that
lysine residues in these peptides are the most likely targets
for biotinylation [16].
We verified that peptide biotinylation approached max-
imal levels under the conditions described in Methods and
materials. First, the time course of biotinylation of peptide
N1–9 was monitored at timed intervals for up to 45 min;
concentrations of peptide, biocytin and biotinidase were
kept constant as described above. Biotinylation of peptide
N1–9 was detectable 15 min after starting the incubation with
biotinidase and reached maximal levels after 45 min (data
Fig. 1. Both N-terminal and C-terminal regions of histone H2A are targets
for biotinylation by biotinidase. Synthetic peptides based on histone H2A
were incubated with biotinidase and biocytin for enzymatic biotinylation.
Peptides were resolved by gel electrophoresis and peptide-bound biotin was
probed using streptavidin peroxidase.
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not shown), consistent with previous studies [15]. Second,
we tested the effects of substrate (biocytin) availability.
Peptide N1–9 was incubated with biotinidase at various
concentrations of biocytin (7.5, 37.5, 75, 112.5 and
150 Amol/L) for 45 min. Biotinylation of N1–9 reached a
plateau at 75 Amol/L of biocytin (data not shown),
consistent with previous studies [13]. Finally, we varied
the concentration of peptide N1–9 in the biotinylation
reaction. The biotinylation signal paralleled the amount of
N1–9 added to incubation mixtures (data not shown).
Next, we identified biotinylation targets in the
N-terminus of histone H2A. A first series of experiments
suggested that K9 is a biotinylation target based on the
following lines of evidence. Peptide N1–9 (containing both
K5 and K9) was heavily biotinylated in response to
incubation with biotinidase (Fig. 2, Lane 1). When K9
was substituted with alanine (peptide K9A1–9), no biotiny-
lation was detectable (Lane 2). In contrast, substitution of
K5 with alanine residues (peptide K5A1–9) did not decrease
biotinylation (Lane 3). When both lysine residues in peptide
N1–9 were substituted with alanines (peptide K5,9A1–9), no
biotinylation was detectable (Lane 4). Biotinylation of K9
by biotinidase was further corroborated using the following
control. Peptide N7–14 contains both K9 and K13 from
histone H2A and was heavily biotinylated in response to
incubation with biocytin and biotinidase (data not shown).
When K13 in N7–14 was substituted with alanine, the
biotinylation signal decreased only moderately; in contrast,
when K9 was substituted with an alanine, the biotinylation
signal decreased substantially (data not shown).
A second series of experiments suggested that K13 in the
N-terminus of histone H2A becomes a target for biotinyla-
tion if the neighboring K15 is modified. This notion is based
on the following lines of evidence. Peptide N12–20 contains
both K13 and K15 and was a poor target for biotinylation by
biotinidase (Fig. 3, Lane 1). However, when K15 was
substituted with an alanine (peptide K15A12–20), K13
became a good target for biotinylation (Lane 2). Substitution
of K13 with an alanine (peptide K13A12–20) did not render
K15 a good target for biotinylation (Lane 3). When both
lysine residues in peptide N12–20 were substituted with
alanine residues (peptide K13,15A12–20), no biotinylation
was detectable (Lane 4). Note that the lysine-to-alanine
substitutions used here are an artificial system that does not
necessarily represent histones from human cells. However,
findings described below suggest that naturally occurring
variations in amino acid sequences (see histone variant
H2AX) and posttranslational modifications of amino acids
(see cross-talk among histone modifications) render K13 a
good target for biotinylation.
The N-terminal tail of human histone H2AX differs
from the tail in histone H2A in two positions [19]:
glutamine in Position 6 is substituted with threonine and
threonine in Position 16 is substituted with serine in histone
H2AX. First, we synthesized the following two peptides
based on the N-terminus of histone H2AX: Q6T1–9=
amino acid sequence SGRGKTGGK and T16S12–20=
AKAKSRSSR. Both peptides were good targets for
biotinylation by biotinidase (Fig. 4, Lanes 1 and 3). Peptide
N7–14 represents a moderate target for biotinylation (see
above) and was used as a control (Lanes 2 and 5). In fact,
the N-terminus of histone H2AX was a better target for
biotinylation than the N-terminus of histone H2A (compare
Lanes 1–3 with Lanes 4–6). Specifically, a peptide
containing both K9 and K13 (Q6T1–9) was a good target
for biotinylation (Lane 1), whereas a peptide containing
K13 and K15 (T16S12–20) was biotinylated only moderately
in response to incubation with biotinidase (Lane 3). Peptide
K5,9A1–9 does not contain any lysine residue and was used
Fig. 2. K9 in histone H2A is a good target for biotinylation by
biotinidase. Synthetic peptides based on histone H2A were incubated
with biotinidase and biocytin for enzymatic biotinylation. Peptides were
resolved by gel electrophoresis and peptide-bound biotin was probed
using streptavidin peroxidase.
Fig. 3. Substitution of K15 in histone H2Awith alanine renders K13 a good
target for biotinylation by biotinidase. Synthetic peptides based on histone
H2A were incubated with biotinidase and biocytin for enzymatic
biotinylation. Peptides were resolved by gel electrophoresis and peptide-
bound biotin was probed using streptavidin peroxidase.
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as a negative control (Lane 7); no biotinylation was
detectable after incubation with biotinidase.
In a next series of experiments, we confirmed that K9
and K13 in variant H2AX are specifically targeted by
biotinylation in analogy to the findings described for histone
H2A. Overall, we observed the same trends for peptides
based on histone H2AX compared with histone H2A.
Peptide Q6T1–9 contains both K9 and K13 from histone
H2AX and was biotinylated in response to incubation with
biotinidase (Fig. 5, Lane 1). Substitution of K9 with alanine
(peptide Q6T,K9A1–9) substantially decreased biotinylation
(Lane 2), whereas substitution of K5 with alanine (peptide
Q6T,K5A1–9) decreased biotinylation only moderately
(Lane 3). Peptide T16S12–20 contains both K13 and K15
and was biotinylated in response to incubation with
biotinidase (Lane 4). When K15 was substituted with
alanine (peptide K15A,T16S12–20), biotinylation decreased
moderately (Lane 5). No biotinylation was detectable when
K13 was substituted with alanine (peptide K13A,T16S12–20;
Lane 6). When both lysine residues in peptide T16S12–20
were substituted with alanine (peptide K13,15A,T16S12–20),
no biotinylation was detectable (Lane 7).
Lysines in the C-terminus of histone H2A were targeted
for biotinylation by biotinidase. The C-terminus of histone
H2A contains three lysine residues in positions 125, 127
and 129. A synthetic peptide including all three of these
lysines (C122–129) was a good substrate for biotinylation
by biotinidase (Fig. 6, Lane 1). Biotinylation decreased
only moderately when K125 and K127 were substituted
with alanine residues (peptide K125,127A122–129; Lane 2),
suggesting that K129 is a good target for biotinylation.
Consistent with this hypothesis, substitution of K125
and K129 (peptide K125,129A122–129) and K127 and
K129 (peptide K127,129A122–129) with alanine residues
caused a considerable decrease of biotinylation (Lanes 3
and 4, respectively). When all lysine residues in peptide
C122–129 were substituted with alanine residues (peptide
K125,127,129A122–129), no biotinylation was detectable
(Lane 5).
The C-terminus of histone H2AX was not a good target
for biotinylation. Note that N-terminal sequences are
Fig. 5. K9 and K13 in histone H2AX are targets for biotinylation by
biotinidase. Synthetic peptides based on histones H2A and H2AX were
incubated with biotinidase and biocytin for enzymatic biotinylation.
Peptides were resolved by gel electrophoresis and peptide-bound biotin
was probed using streptavidin peroxidase.
Fig. 6. K125, K127 and K127 in the C-terminus of histone H2A are targets
for biotinylation by biotinidase. Synthetic peptides based on histone H2A
were incubated with biotinidase and biocytin for enzymatic biotinylation.
Peptides were resolved by gel electrophoresis and peptide-bound biotin was
probed using streptavidin peroxidase.
Fig. 4. The N-terminus of H2AX is a good substrate for biotinylation by
biotinidase. Synthetic peptides based on histone H2AX were incubated with
biotinidase and biocytin for enzymatic biotinylation. Peptides were resolved
by gel electrophoresis and peptide-bound biotin was probed using
streptavidin peroxidase.
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highly conserved between histones H2A and H2AX but
that the C-terminal sequences of these two histones are
unique [19]. In this study, we synthesized the following
three peptides based on the C-terminus of histone H2AX:
C113–121=AVLLPKKTS; C122–131=ATVGPKAPSG; and
C132–142=GKKATQASQEY. These peptides were not
biotinylated in response to incubation with biotinidase
(data not shown).
3.2. Cross-talk among histone modifications
Previous studies suggested that acetylation and methyla-
tion of histone H4 affect subsequent biotinylation [16]. Of
note, K5, K9, K13 and other lysine residues in human histone
H2A are targets for acetylation [7]. We provide evidence that
acetylation and methylation of histone H2A are likely to
affect subsequent biotinylation. Peptide N1–9 (containing
both K5 and K9) was heavily biotinylated in response to
incubation with biotinidase and was used as a positive control
(Fig. 7, Lane 1). Acetylation of K5 caused a moderate
decrease in the biotinylation of K9 (Lane 2). A peptide
containing acetylated K9 and free K5 was not a target for
biotinylation (Lane 3). This is consistent with our observation
that K9 but not K5 is a target for biotinylation (see above).
Moreover, dimethylation of R3 did not cause a change in the
biotinylation signal (data not shown) because the adjacent K5
is not a biotinylation target. Peptide N7–14 (containing both
K9 and K13) was a good target for biotinylation (Lane 4).
Again, acetylation of K9 decreased the biotinylation signal
substantially (data not shown). Moreover, both dimethylation
and acetylation of K13 decreased the biotinylation of K9
(Lanes 5 and 6). On the other hand, dimethylation R11
considerably increased the enzymatic biotinylation of K9 or
K13 (or both) by biotinidase (data not shown). Peptide N12–20
(containing both K13 and K15) was a poor target for
biotinylation, but dimethylation of R17 substantially in-
creased the biotinylation of K13 or K15 (or both) (data not
shown). Increased biotinylation of lysine residues in response
to biotinylation of adjacent arginine residues is consistent
with previous studies [16].
3.3. Biotinylation of histone H2A in human cells
Human cells contain biotinylated histone H2A as judged
by using novel biotinylation site-specific antibodies. In a
first series of experiments, we raised antibodies to
K9-biotinylated and K13-biotinylated histone H2A and
validated the specificity of these antibodies by using
synthetic peptides. We ran the same two peptides that
were used for injections into rabbits (N1–12bioK9 and
N10–25bioK13) on a polyacrylamide gel and probed the
biotin tag by using streptavidin peroxidase. The two
peptides produced a similar signal (Fig. 8A, compare Lanes
1 and 2), suggesting that biotinylation of peptides and
loading of peptides on gels were similar. Second, the two
peptides and a nonbiotinylated control (N1–20) were probed
with antibodies to K9-biotinylated and K13-biotinylated
histone H2A. Anti-K9bio antibody did not bind to peptide
N1–20 (Lane 3) but cross-reacted with both biotinylated
peptides N10–25bioK9 and N10–25bioK13 (Lanes 4 and 5);
preimmune serum did not produce a detectable signal (data
Fig. 7. Methylation and acetylation of amino acids in the N-terminus of
histone H2A affect the subsequent biotinylation of adjacent lysine residues
by biotinidase. Synthetic peptides based on histone H2A were incubated
with biotinidase and biocytin for enzymatic biotinylation. Peptides were
resolved by gel electrophoresis and peptide-bound biotin was probed using
streptavidin peroxidase.
Fig. 8. Western blot analysis of biotinylated histones. (A) Synthetic
peptides based on histone H2A were probed with streptavidin peroxidase
or antibodies to histone H2A, biotinylated in position K9 or K13. Lanes
1, 4 and 7=peptide N1–12bioK9 [SGRGKQGGK(biotin)ARAC]; Lanes
2, 5 and 8=peptide N10–24bioK13 [ARAK(biotin)AKTRSSRAGLQC];
and Lanes 3 and 6=peptide N1–20 (SGRGKQGGKARAKAKTRSSR).
(B) Jurkat cells contain biotinylated histone H2A. Nuclear histones were
purified by acid extraction. Histones were resolved by gel electropho-
resis and probed as follows: Lane 1, streptavidin peroxidase; Lane 2,
antibody anti-K9bio; Lane 3, antibody anti-K13bio; Lane 4, preimmune
serum for antibody anti-K9bio; and Lane 5, preimmune serum for
antibody anti-K13bio.
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not shown). In contrast, anti-K13bio antibody did not bind to
N1–20 and N10–25bioK9 (Lanes 6 and 7) but was specific for
peptide N10–25bioK13 containing biotinylated K13 (Lane 8);
preimmune serum did not produce a detectable signal (data
not shown). Moreover, antibodies to biotinylated histone
H2A did not cross-react with biotinylated peptides based
on histone H4: N6–15bioK8=GGK(biotin)GLGKGGA and
N6–15bioK12=GGKGLGK(biotin)GGA (data not shown).
Collectively, these data suggest that both anti-K9bio and
anti-K13bio are specific for biotinylated histone H2A
peptides and are unlikely to cross-react with other biotiny-
lated histones (see below). These data also suggest that
antibody anti-K13bio is biotinylation site specific, whereas
antibody anti-K9bio cross-reacts with both biotinylated K9
and K13.
Next, histone extracts from Jurkat cell nuclei were
probed with antibodies to biotinylated histone H2A. The
histone extracts contained biotinylated histones H1, H2A,
H2B, H3 and H4 as judged by staining with streptavidin
peroxidase (Fig. 8B, Lane 1). The polyclonal antibodies
raised in this study were specific for histone H2A and did
not cross-react with other classes of histones (Lanes 2
and 3). When biotinylated histones were probed with
preimmune serum, no detectable signal was produced
(Lanes 4 and 5).
Biotinylated histone H2A localized to the nucleus in
JAr choriocarcinoma cells as judged by confocal micros-
copy and antibodies against biotinylated histone H2A.
First, the subcellular localization of K9-biotinylated
histone H2A was visualized using antibody anti-K9bio
(Fig. 9A). Nuclear and cytoplasmic compartments were
stained with DAPI and rhodamine phalloidin, respectively
(Fig. 9A). Merged images are consistent with nuclear
localization of K9-biotinylated histone H2A. Preimmune
serum did not generate a detectable signal. Analogous
experiments were conducted for K13-biotinylated histone
H2A. Antibody anti-K13bio localized primarily to the cell
nucleus (Fig. 9B).
Both biotinidase and HCS showed considerable nuclear
localization in JAr cells. First, we validated the specificity
of antibodies against biotinidase and HCS using synthetic
peptides as described for histone antibodies (data not
Fig. 9. Biotinylated histone H2A, biotinidase and HCS localize primarily to the nucleus in JAr choriocarcinoma cells. Cells were stained with antibodies to
K9-biotinylated histone H2A (A), K13-biotinylated histone H2A (B), biotinidase (C) and HCS (D). The nuclear and cytoplasmic compartments were stained
using DAPI and rhodamine phalloidin, respectively. Images entitled Merged were created by overlaying images obtained by staining with antibody, DAPI and
rhodamine phalloidin. Preimmune sera were used as negative controls.
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shown). The subcellular localization of biotinidase in JAr
cells was visualized using confocal microscopy and anti-
biotinidase (Fig. 9C). Nuclear and cytoplasmic compart-
ments were stained with DAPI and rhodamine phalloidin,
respectively (Fig. 9C). Merged images were consistent
with nuclear localization of biotinidase. Preimmune serum
did not generate a detectable signal (Fig. 9C). Analogous
experiments were conducted for HCS. Anti-HCS also
localized to the cell nucleus; preimmune serum (negative
control) did not generate a detectable signal (Fig. 9D).
4. Discussion
This study provides evidence that (1) K9 and K13 in the
N-terminus of histones H2A and H2AX are targets for
biotinylation by biotinidase; (2) K125, K127 and K129 in the
C-terminus of histone H2A are targets for biotinylation by
biotinidase; (3) K9-biotinylated andK13-biotinylated histone
H2A reside in human cell nuclei; (4) acetylation and dime-
thylation of lysine residues in histones decrease subsequent
biotinylation of adjacent lysine residues; (5) dimethylation of
arginine residues increases subsequent biotinylation of
adjacent lysine residues; and (6) both HCS and biotinidase
reside primarily in the nuclear compartment.
The findings presented here are likely to generate novel
insights into biologic functions of histone biotinylation.
Ongoing studies in our laboratory have provided evidence
that biotinylation of distinct lysine residues in various
classes of histones might play unique roles in the cellular
response to double-strand breaks of DNA, chromatin
condensation, telomere structure and nucleoli structure
(unpublished observations). Specifically, we propose that
biotinylation of histone H2A might participate in the
following processes: First, biotinylation of histone H2A
targets K9, which is also a target for acetylation; these two
modifications are mutually exclusive. It has been proposed
that acetylation of K9 in histone H2A might be associated
with transcriptionally active chromatin [28]. We speculate
that biotinylation of K9 decreases the transcriptional activity
of chromatin, mediated by decreased acetylation of K9.
Second, phosphorylation of histone H2AX is known to
participate in DNA repair events, mediated by accumulation
at sites of DNA damage [11]. Biotinylation of histones is
known to change in response to DNA damage [17,18], but it
remains to be determined whether biotinylation of K9 and
K13 in histone H2A plays a role in repair events. Third,
biotinylation of lysines in the C-terminus of histone H2A
might affect histone–histone interactions in nucleosomes
based on the following lines of reasoning. Histone H2A is
unique among core histones in having its C-terminal tail
exposed at the nucleosomal surface [1,8]. However, the
larger part of the C-terminal domain of histone H2A and
other histones is buried inside the nucleosomes [1]. The
C-terminal histone fold domain is predominantly a-helical
with a long central helix bordered on each side by a loop
segment (h-bridge, hinge region) and a shorter helix [1].
The long helix acts as a dimerization interface between
histones [1]. We speculate that the biotinylation of
C-terminal lysine residues in histone H2A affects the
dimerization of histones. Note that K125 and K127 are
also targets for methylation [7]. The effects of lysine
methylation in the C-terminus of histone H2A are uncertain,
but interactions between biotinylation and methylation are
likely to occur in vivo.
We shall point out the following uncertainty of the
studies presented here. Whereas the existence of
K9-biotinylated and that of K13-biotinylated histone
H2A have been confirmed by using antibodies, no such
antibodies have yet been raised against histone H2A
biotinylated in the C-terminus. Hence, while this study
suggests that K125, K127 and K129 are targets for
biotinidase, the existence of these modifications in vivo
awaits formal confirmation.
Previous studies suggested that dimethylation of arginine
residues in histone H4 increases biotinylation of adjacent
lysine residues [16]. We observed a similar pattern for
histone H2A: dimethylation of R11 increased the biotiny-
lation of K9 or K13 (or both) by biotinidase and
dimethylation of R17 increased the biotinylation of K13
or K15 (or both). Note that arginine residues in histones can
be converted to citrulline and ornithine by deimination
[29,30]. Citrulline and ornithine residues are good targets
for biotinylation by biotinidase (Y.C. Chew and J. Zempleni,
unpublished observation). Collectively, posttranslational
modifications of arginine residues are likely to play
important roles in histone biotinylation.
Finally, this study provides evidence that significant
fractions of cellular biotinidase and HCS localize to the
nuclear compartment, consistent with a role of these
enzymes in chromatin structure. Previous studies are
consistent with a nuclear localization of HCS [14]. These
previous studies suggested that most HCSs localized to the
nuclear periphery rather than to the nucleoplasm. The
functional significance of this observation is currently
being investigated. The amino acid residues in histones
that are targets for biotinylation by HCS await identifica-
tion, whereas targets for biotinidase have been character-
ized [15,16]. Unlike that for HCS, the cellular distribution
of biotinidase is controversial. This study and a previous
study [31] are consistent with nuclear localization of
biotinidase; in contrast, Stanley et al. [32] suggested that
biotinidase localizes to the cytoplasm but not to the
nucleus. The reasons for these apparently conflicting
observations are unknown.
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